| |
News Highlights
January 18, 2012
New Patents Expand Concert Pharmaceuticals’ Patent Estate of Deuterium-Based Therapeutics; 25 Patents Issued Worldwide
January 3, 2012
Concert Pharmaceuticals to Present at the J.P. Morgan Healthcare
Conference on January 10, 2012
November 15, 2011
Concert Pharmaceuticals Announces NIH Research Collaboration for Rare and Neglected Diseases
November 14, 2011
Concert Presents Phase 1 Data for CTP-499 at ASN Kidney Week Meeting; Supports Advancement into Phase 2 in Diabetic Nephropathy Patients
more... |
|
Concert uses deuterium-based chemistry to create and develop highly differentiated new medicines by leveraging decades of pharmaceutical and clinical experience to reduce time, risk and expense.
Concert in the
news... a selection of news stories featuring Concert.
Upcoming Events
Concert will present at the 2012 Epilepsy Pipeline Update Conference, February 2-4, 2012 in San Francisco
Business Development/Strategic Partnering
Concert business development will present at BioNetwork East 2012, March 5-7, 2012 in Miami, FL
|
|
